Diarrhea in solid organ transplant recipients

Current Opinion in Infectious Diseases

Volumn 28, Issue 4, 2015, Pages 308-316

  Angarone, Michael ^a   Ison, Michael G ^a,b  

^a Division of Infectious Disease   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Clostridium difficile; cytomegalovirus; diarrhea; norovirus; transplant recipients

Indexed keywords

CLOSTRIDIUM DIFFICILE INFECTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIARRHEA; GRAFT RECIPIENT; HUMAN; NONHUMAN; NOROVIRUS; NOROVIRUS INFECTION; ORGAN TRANSPLANTATION; PEPTOCLOSTRIDIUM DIFFICILE; REVIEW; SURGICAL PATIENT; CLOSTRIDIUM INFECTIONS; IMMUNOCOMPROMISED PATIENT; ISOLATION AND PURIFICATION; RISK FACTOR; TRANSPLANTATION; VIRUS DISEASES;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CYTOMEGALOVIRUS; DIARRHEA; HUMANS; IMMUNOCOMPROMISED HOST; NOROVIRUS; RISK FACTORS; TRANSPLANT RECIPIENTS; TRANSPLANTS; VIRUS DISEASES;

EID: 84937942856     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000172     Document Type: Review

References (81)

1. Ekberg H, Kyllönen L, Madsen S, et al. Increased prevalence of gastrointestinal symptoms associated with impaired quality of life in renal transplant recipients. Transplantation 2007; 83:282-289.
2. Ekberg H, Kyllö nen L, Madsen S, et al. Clinicians underestimate gastrointestinal symptoms and overestimate quality of life in renal transplant recipients: a multinational survey of nephrologists. Transplantation 2007; 84:1052-1054.
3. Gil-Vernet S, Amado A, Ortega F, et al. Gastrointestinal complications in renal transplant recipients: Mitos study. Transplantat Proc 2007; 39:2190-2193.
4. Herrero JI, Benlloch S, Bernardos A, et al. Gastrointestinal complications in liver transplant recipients: Mitos study. Transplant Proc 2007; 39:2311-2313.
5. Jokinen JJ, Hämmä inen P, Lemström KB, et al. Association between gastrointestinal symptoms and health-related quality of life after heart transplantation. J Heart Lung Transplant 2010; 29:1388-1394.
6. Guerrant RL, Van Gilder T, Steiner TS, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001; 32:331-351.
7. Arslan H, Inci EK, Azap OK, et al. Etiologic agents of diarrhea in solid organ recipients. Transplant Infect Dis 2007; 9:270-275.
8. Bunnapradist S, Neri L, Wong W, et al. Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality. Am J Kidney Dis 2008; 51:478-486.
9. Echenique IA, Penugonda S, Stosor V, et al. Diagnostic yields in solid organ transplant recipients admitted with diarrhea. Clin Infect Dis 2015; 60:729-737.
10. Hardinger KL, Brennan DC, Lowell J, Schnitzler MA. Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil. Transplant Int 2004; 17:609-616.
11. Maes B, Hadaya K, de Moor B, et al. Severe diarrhea in renal transplant patients: results of the didact study. Am J Transplant 2006; 6:1466-1472.
12. Al-Absi AI, Cooke CR, Wall BM, et al. Patterns of injury in mycophenolate mofetil-related colitis. Transplant Proc 2010; 42:3591-3593.
13. Glander P, Hambach P, Braun KP, et al. Pretransplant inosine monophosphate dehydrogenase activity is associated with clinical outcome after renal transplantation. Am J Transplant 2004; 4:2045-2051.
14. Behrend M. Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management. Drug Safety 2001; 24:645-663.
15. Kim J, Shaklee JF, Smathers S, et al. Risk factors and outcomes associated with severe Clostridium difficile infection in children. Pediatr Infect Dis J 2012; 31:134-138.
16. Helderman JH, Goral S. Gastrointestinal complications of transplant immunosuppression. J Am Soc Nephrol 2002; 13:277-287.
17. The U.S. Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994; 331:1110-1115.
18. Bunnapradist S, Ambuhl PM. Impact of gastrointestinal-related side effects on mycophenolate mofetil dosing and potential therapeutic strategies. Clin Transplant 2008; 22:815-821.
19. Pant C, Deshpande A, Larson A, et al. Diarrhea in solid-organ transplant recipients: a review of the evidence. Curr Med Res Opin 2013; 29:1315-1328.
20. Wu G, Selvaggi G, Nishida S, et al. Graft-versus-host disease after intestinal and multivisceral transplantation. Transplantation 2011; 91:219-224.
21. Zhang Y, Ruiz P. Solid organ transplant-associated acute graft-versus-host disease. Arch Pathol Lab Med 2010; 134:1220-1224.
22. Kohler S, Pascher A, Junge G, et al. Graft versus host disease after liver transplantation: a single center experience and review of literature. Transpl Int 2008; 21:441-451.
23. Jagadeesh D, Woda BA, Draper J, Evens AM. Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations. Curr Treatment Options Oncol 2012; 13:122-136.
24. Pickhardt PJ, Siegel MJ. Posttransplantation lymphoproliferative disorder of the abdomen: Ct evaluation in 51 patients. Radiology 1999; 213:73-78.
25. Younes BS, Ament ME, McDiarmid SV, et al. The involvement of the gastrointestinal tract in posttransplant lymphoproliferative disease in pediatric liver transplantation. J Pediatr Gastroenterol Nutr 1999; 28:380-385.
26. Cohen SH, Gerding DN, Johnson S, et al., Society for Healthcare Epidemiology of A, Infectious Diseases Society of A. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of america (shea) and the infectious diseases society of america (idsa). Infect Control Hosp Epidemiol 2010; 31:431-455.
27. Surawicz CM, Brandt LJ, Binion DG, et al.Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013; 108:478-498; quiz 499.
28. Boutros M, Al-Shaibi M, Chan G, et al. Clostridium difficile colitis: increasing incidence, risk factors, and outcomes in solid organ transplant recipients. Transplantation 2012; 93:1051-1057.
29. Hsu JL, Enser JJ, McKown T, et al. Outcomes of Clostridium difficile infection in recipients of solid abdominal organ transplants. Clin Transplant 2014; 28:267-273.
30. Lee JT, Kelly RF, Hertz MI, et al. Clostridium difficile infection increases mortality risk in lung transplant recipients. J Heart Lung Transplant 2013; 32:1020-1026.
31. Pant C, Anderson MP, O'Connor JA, et al. Association of Clostridium difficile infection with outcomes of hospitalized solid organ transplant recipients: results from the 2009 nationwide inpatient sample database. Transpl Infect Dis 2012; 14:540-547.
32. Stelzmueller I, Goegele H, Biebl M, et al. Clostridium difficile colitis in solid organ transplantation: a single-center experience. Digest Dis Sci 2007; 52:3231-3236.
33. Loo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011; 365:1693-1703.
34. Lo Vecchio A, Zacur GM. Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options. Curr Opin Gastroenterol 2012; 28:1-9.
35. Dubberke ER, Burdette SD; Practice ASTIDCo. Clostridium difficile infections in solid organ transplantation. Am J Transplant 2013; 13 (Suppl 4):42-49.
36. Munoz P, Giannella M, Alcala L, et al. Clostridium difficile-associated diarrhea in heart transplant recipients: is hypogammaglobulinemia the answer? J Heart Lung Transplant 2007; 26:907-914.
37. Friedman-Moraco RJ, Mehta AK, Lyon GM, Kraft CS. Fecal microbiota transplantation for refractory Clostridium difficile colitis in solid organ transplant recipients. Am J Transplant 2014; 14:477-480.
38. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011; 53:994-1002.
39. Kelly CR, Ihunnah C, FischerM, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol 2014; 109:1065-1071.
40. Bok K, Green KY. Norovirus gastroenteritis in immunocompromised patients. N Engl J Med 2012; 367:2126-2132.
41. Kamalkumar BS, Agarwal SK, Garg P, et al. Acute pancreatitis with CMV papillitis and cholangiopathy in a renal transplant recipient. Clin Exp Nephrol 2009; 13:389-391.
42. Zheng DP, Ando T, Fankhauser RL, et al. Norovirus classification and proposed strain nomenclature. Virology 2006; 346:312-323.
43. Gastanaduy PA, Hall AJ, Curns AT, et al. Burden of norovirus gastroenteritis in the ambulatory setting: United States, 2001-2009. J Infect Dis 2013; 207:1058-1065.
44. Hall AJ, Lopman BA, Payne DC, et al. Norovirus disease in the United States. Emerg Infect Dis 2013; 19:1198-1205.
45. Lee LY, Ison MG. Diarrhea caused by viruses in transplant recipients. Transpl Infect Dis 2014; 16:347-358.
46. Patel MM, Hall AJ, Vinje J, Parashar UD. Noroviruses: a comprehensive review. J Clin Virol 2009; 44:1-8.
47. Marks PJ, Vipond IB, Carlisle D, et al. Evidence for airborne transmission of norwalk-like virus (NLV) in a hotel restaurant. Epidemiol Infect 2000; 124:481-487.
48. Fankhauser RL, Monroe SS, Noel JS, et al. Epidemiologic and molecular trends of 'norwalk-like viruses' associated with outbreaks of gastroenteritis in the United States. J Infect Dis 2002; 186:1-7.
49. Rockx B, De Wit M, Vennema H, et al. Natural history of human calicivirus infection: a prospective cohort study. Clin Infect Dis 2002; 35:246-253.
50. Farkas T, Jiang X. Rotavirus, caliciviruses, astroviruses, enteric adenoviruses, and other viruses causing acute gastroenteritis. Washington, DC: ASM Press; 2009.
51. Atmar J, Mullen E. Norovirus in immunocompromised patients. Oncol Nurs Forum 2013; 40:434-436.
52. Kaufman SS, Chatterjee NK, Fuschino ME, et al. Calicivirus enteritis in an intestinal transplant recipient. Am J Transplant 2003; 3:764-768.
53. Florescu DF, Hill LA, McCartan MA, Grant W. Two cases of norwalk virus enteritis following small bowel transplantation treated with oral human serum immunoglobulin. Pediatr Transplant 2008; 12:372-375.
54. Gallimore CI, Lewis D, Taylor C, et al. Chronic excretion of a norovirus in a child with cartilage hair hypoplasia (CHH). J Clin Virol 2004; 30:196-204.
55. Kaufman SS, Green KY, Korba BE. Treatment of norovirus infections: moving antivirals from the bench to the bedside. Antiviral Res 2014; 105:80-91.
56. Nilsson M, Hedlund KO, Thorhagen M, et al. Evolution of human calicivirus rna in vivo: accumulation of mutations in the protruding p2 domain of the capsid leads to structural changes and possibly a new phenotype. J Virol 2003; 77:13117-13124.
57. Simon A, Schildgen O, Maria Eis-Hubinger A, et al. Norovirus outbreak in a pediatric oncology unit. Scand J Gastroenterol 2006; 41:693-699.
58. Roos-Weil D, Ambert-Balay K, Lanternier F, et al. Impact of norovirus/sapovirus-related diarrhea in renal transplant recipients hospitalized for diarrhea. Transplantation 2011; 92:61-69.
59. Schorn R, Hohne M, Meerbach A, et al. Chronic norovirus infection after kidney transplantation: Molecular evidence for immune-driven viral evolution. Clin Infect Dis 2010; 51:307-314.
60. Westhoff TH, Vergoulidou M, Loddenkemper C, et al. Chronic norovirus infection in renal transplant recipients. Nephrol Dial Transplant 2009; 24:1051-1053.
61. Chehade H, Girardin E, Delich V, et al. Acute norovirus-induced agranulocytosis in a pediatric kidney transplant recipient. Transpl Infect Dis 2012; 14:E27-29.
62. Ebdrup L, Bottiger B, Molgaard H, Laursen AL. Devastating diarrhoea in a heart-transplanted patient. J Clin Virol 2011; 50:263-265.
63. Florescu DF, Hermsen ED, Kwon JY, et al. Is there a role for oral human immunoglobulin in the treatment for norovirus enteritis in immunocompromised patients? Pediatr Transplant 2011; 15:718-721.
64. Rossignol JF, El-Gohary YM. Nitazoxanide in the treatment of viral gastroenteritis: a randomized double-blind placebo-controlled clinical trial. Aliment Pharmacol Therapeut 2006; 24:1423-1430.
65. Jiang X, Huang P, Zhong W, et al. Human milk contains elements that block binding of noroviruses to human histo-blood group antigens in saliva. J Infect Dis 2004; 190:1850-1859.
66. Children's Hospital Medical Center C, England MsMBoN. Human breastmilk in young children with norovirus infection of the gut. In ClinicalTrials.gov [Internet] Bethesda (MD): National Library of Medicine (US). 2000. http://clinicaltrials.gov/show/NCT00004451 NLM Identifier: NCT02371538. [cited 30 March 2015]
67. Eid AJ, Razonable RR. New developments in the management of cytomegalovirus infection after solid organ transplantation. Drugs 2010; 70:965-981.
68. Kotton CN, Kumar D, Caliendo AM, et al., Transplantation Society International CMVCG. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation 2013; 96:333-360.
69. Bobak DA. Gastrointestinal infections caused by cytomegalovirus. Curr Infect Dis Rep 2003; 5:101-107.
70. Dahman M, Krell R, Brayman K, et al. Simultaneous Clostridium difficileassociated colitis and late-onset intestinal cytomegalovirus disease in a renal transplant recipient. Ann Transplant 2010; 15:72-76.
71. Hampton DD, Poleski MH, Onken JE. Inflammatory bowel disease following solid organ transplantation. Clin Immunol 2008; 128:287-293.
72. Veroux M, Puzzo L, Corona D, et al. Cytomegalovirus and Clostridium difficile ischemic colitis in a renal transplant recipient: a lethal complication of antirejection therapy? Urologia Internationalis 2007; 79:177-179. [discussion 180]
73. Drage M, Reid A, Callaghan CJ, et al. Acute cytomegalovirus cholecystitis following renal transplantation. Am J Transplant 2009; 9:1249-1252.
74. Lee SO, Razonable RR. Current concepts on cytomegalovirus infection after liver transplantation. World J Hepatol 2010; 2:325-336.
75. Durand CM, Marr KA, Arnold CA, et al. Detection of cytomegalovirus DNA in plasma as an adjunct diagnostic for gastrointestinal tract disease in kidney and liver transplant recipients. Clin Infect Dis 2013; 57:1550-1559.
76. Alles AJ, Waldron MA, Sierra LS, Mattia AR. Prospective comparison of direct immunofluorescence and conventional staining methods for detection of giardia and cryptosporidium spp. in human fecal specimens. J Clin Microbiol 1995; 33:1632-1634.
77. Polage CR, Stoddard GJ, Rolfs RT, Petti CA. Physician use of parasite tests in the United States from 1997 to 2006 and in a Utah cryptosporidiumoutbreak in 2007. J Clin Microbiol 2011; 49:591-596.
78. From the centers for disease control and prevention. Preliminary foodnet data on the incidence of foodborne illnesses: selected sites, United States, 1999. J Am Med Assoc 2000; 283:1818-1819.
79. Bhadauria D, Goel A, Kaul A, et al. Cryptosporidium infection after renal transplantation in an endemic area. Transpl Infect Dis 2015; 17:48-55.
80. Bonatti H, Barroso LF 2nd, Sawyer RG, et al. Cryptosporidium enteritis in solid organ transplant recipients: multicenter retrospective evaluation of 10 cases reveals an association with elevated tacrolimus concentrations. Transpl Infect Dis 2012; 14:635-648.
81. Coste JF, Vuiblet V, Moustapha B, et al. Microbiological diagnosis of severe diarrhea in kidney transplant recipients by use of multiplex pcr assays. J Clin Microbiol 2013; 51:1841-1849.